Results 171 to 180 of about 69,645 (263)
Early Detection of Septic Patient's Deterioration Based on the Modified Early Obstetric Warning Score (MEOWS)-Case Report. [PDF]
Mickiewicz P +4 more
europepmc +1 more source
ABSTRACT Background Cell therapy, particularly those utilizing mesenchymal stem/stromal cells (MSCs), is gaining traction as a therapeutic option for regenerative treatment in patients with limited therapeutic options. Although the safety of MSC‐based interventions is well established, uncertainties remain regarding how genetic abnormalities and ...
Marzena Zychowicz +12 more
wiley +1 more source
Correction: Bednarek et al. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. <i>Diagnostics</i> 2026, <i>16</i>, 786. [PDF]
Bednarek AM +4 more
europepmc +1 more source
This study shows that tafoxiparin 300 mg can increase the rate of cervical ripening and the likelihood of spontaneous onset of labor, while also reducing the duration of labor in women achieving spontaneous onset of labor. The favorable safety profile of tafoxiparin suggests suitability for routine clinical use, including home administration.
Gunvor Ekman‐Ordeberg +11 more
wiley +1 more source
The Role of <i>REL</i> and <i>IL2</i> and Their Polymorphisms in the Pathogenesis of Vitiligo-Exploratory Genetic Association Study. [PDF]
Kądziela M +5 more
europepmc +1 more source
Learning opportunities in eclampsia care: A ten‐year audit from Norway, 2013–2022
Audit of eclampsia identified learning for obstetric care. Improved hypertension management and prophylactic magnesium sulfate represent opportunities for prevention, while cerebral imaging and follow‐up postpartum were underused. Clinicians need to consider differential diagnosis in pregnant and postpartum women with seizures.
Camilla Tjønneland Mentzoni +24 more
wiley +1 more source
STAT3 dominant negative Hyper-IgE syndrome: A patient report with actionable genomic findings. [PDF]
Bloom AS +6 more
europepmc +1 more source
Extracorporeal albumin dialysis (OPAL) effectively reduces bilirubin and improves other laboratory markers in posthepatectomy liver failure, particularly in secondary forms. It may serve as a bridging therapy to support hepatic recovery in critically ill patients, although prospective studies are needed to confirm its impact on survival.
Dorian Marckmann +16 more
wiley +1 more source

